These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3158320

  • 41. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C, Thaipisuttikul Y, Pinjaroen S, Krisanapan O, Benjawang W, Koster A, Doesburg W.
    Int J Fertil Menopausal Stud; 1996; 41(4):423-9. PubMed ID: 8894800
    [Abstract] [Full Text] [Related]

  • 42. [Oral contraception with low-dose progestagen].
    Heinzl S.
    Med Monatsschr Pharm; 1989 Apr; 12(4):123-4. PubMed ID: 2657358
    [Abstract] [Full Text] [Related]

  • 43. Effects of two triphasic oral contraceptives containing ethinylestradiol plus levonorgestrel or gestodene on blood coagulation and fibrinolysis.
    Omsjø IH, Oian P, Maltau JM, Osterud B.
    Acta Obstet Gynecol Scand; 1989 Apr; 68(1):27-30. PubMed ID: 2508417
    [Abstract] [Full Text] [Related]

  • 44. Influence of modern low-dose oral contraceptives on hemostasis.
    Daume E.
    Adv Contracept; 1990 Dec; 6 Suppl():51-67; discussion 68. PubMed ID: 2149806
    [Abstract] [Full Text] [Related]

  • 45. Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.
    Luyckx AS, Gaspard UJ, Romus MA, Grigorescu F, De Meyts P, Lefèbvre PJ.
    Fertil Steril; 1986 May; 45(5):635-42. PubMed ID: 2938985
    [Abstract] [Full Text] [Related]

  • 46. Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
    Halbe HW, de Melo NR, Bahamondes L, Petracco A, Lemgruber M, de Andrade RP, da Cunha DC, Guazelli CA, Baracat EC.
    Eur J Contracept Reprod Health Care; 1998 Sep; 3(3):113-20. PubMed ID: 9853201
    [Abstract] [Full Text] [Related]

  • 47. Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
    Bergink EW, Kloosterboer HJ, Lund L, Nummi S.
    Contraception; 1984 Jul; 30(1):61-72. PubMed ID: 6236951
    [Abstract] [Full Text] [Related]

  • 48. Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
    Coenen CM, Thomas CM, Borm GF, Rolland R.
    Int J Fertil Menopausal Stud; 1995 Jul; 40 Suppl 2():92-7. PubMed ID: 8574256
    [Abstract] [Full Text] [Related]

  • 49. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control and tolerance.
    Endrikat J, Jaques MA, Mayerhofer M, Pelissier C, Müller U, Düsterberg B.
    Contraception; 1995 Oct; 52(4):229-35. PubMed ID: 8605781
    [Abstract] [Full Text] [Related]

  • 50. A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
    Winkler UH, Daume E, Sudik R, Oberhoff C, Bier U, Hallmann C, Andreas JO, Schindler AE.
    Eur J Contracept Reprod Health Care; 1999 Sep; 4(3):145-54. PubMed ID: 10574640
    [Abstract] [Full Text] [Related]

  • 51. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N, Porcelli A, Petrelli P, Amedeo M, Crivello T, Ferraris G.
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract] [Full Text] [Related]

  • 52. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
    Bilotta P, Favilli S.
    Minerva Ginecol; 1987 Dec; 39(12):855-69. PubMed ID: 3329705
    [No Abstract] [Full Text] [Related]

  • 53. Development of an oral contraceptive containing a new progestogen, desogestrel, and 30 micrograms ethinylestradiol. Report on clinical studies from Scandinavia.
    Acta Obstet Gynecol Scand Suppl; 1982 Dec; 111():1-60. PubMed ID: 6216716
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
    Kloosterboer HJ, Rekers H.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):370-3. PubMed ID: 2142577
    [Abstract] [Full Text] [Related]

  • 56. Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
    Kluft C, Meijer P, LaGuardia KD, Fisher AC.
    Contraception; 2008 Feb; 77(2):77-83. PubMed ID: 18226669
    [Abstract] [Full Text] [Related]

  • 57. Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
    Gevers Leuven JA, Kluft C, Bertina RM, Hessel LW.
    J Lab Clin Med; 1987 Jun; 109(6):631-6. PubMed ID: 3108429
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.